longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Cerus

CERS

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -77.25, below the reasonable range, cheaper than 92.34% of the time in the past 1 years, and the industry ranks 42/45, the industry Median -0.42.

-77.25xP/E
$2.60Stock price
$-0.03Earnings per share
-77.25xP/E
Stock price$2.60Earnings per share$-0.03

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-27.92x
Typical range
-64.41x–-21.64x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
017345168

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
BLCOUSBausch + Lomb
-35.61x94.03%$6.09B
MMEDUSMiniMed
-18.40x146.72%$5.78B
NEOGUSNeogen
-374.56x316.68%$2.96B
ESTAUSEstablishment Labs
-51.92x30.16%$2.02B
XRAYUSDentsply Sirona
-3.57x113.34%$1.95B
KIDSUSOrthopediatrics
-14.68x27.74%$583.03M
CERSUSCerus
-77.25x56.25%$523.96M
SMTIUSSanara Medtech
-10.09x104.59%$322.96M
OSURUSOraSure Tech
-5.60x29.79%$275.18M
RXSTUSRxSight
-4.30x0.58%$201.73M
SKYAUSSkyAI
-0.20x--$78.28M
ZTEKFUSZENTEK LTD
-7.92x--$59.46M
TELAUSTela Bio
-1.42x17.67%$58.36M
XTNTUSXtant Med
-4.72x477.77%$52.61M
NSPRUSInspireMD
-0.67x--$34.91M
RMTIUSRockwell Medical
-6.59x32.67%$34.54M
RVPUSRetractable Tech
-5.77x--$20.80M
CUPRUSCuprina
-3.65x--$13.17M
LUCYUSInnovative Eyewear
-1.03x--$7.94M
AIDXUS20/20 Biolabs
-0.77x44.74%$5.45M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.